HOME >> BIOLOGY >> NEWS
Bird flu poses threat to international security, Illinois scholar says

In the past, when government leaders, policymakers and scholars have turned their attention to peace and security issues, the talk invariably has focused on war, arms control or anti-terrorism strategies. But Julian Palmore believes it's time to expand the scope of the conversation.

"One thing that is not talked about enough is infectious diseases," said Palmore, a mathematics professor at the University of Illinois at Urbana-Champaign and the director of the university's Program in Arms Control, Disarmament and International Security. "Of course, the spread of AIDS has been and continues to be a major concern worldwide," he said, "but an even greater threat, with regard to international security, may well be avian influenza," or bird flu, as it's commonly called.

And while biologists, epidemiologists and other scientists are engaged in efforts to better understand how the disease is contracted and spread in animals and in humans, Palmore said world leaders and policymakers need to seriously consider the potential international security implications that would result from an avian influenza pandemic.

"Natural disasters, especially pandemics, can and do affect international security in many ways," the U. of I. professor wrote in an article titled "Highly Pathogenic Avian Influenza: A Clear and Present Danger to International Security," scheduled for publication in an upcoming issue of the journal Defense & Security Analysis.

"They can have disastrous effects on countries' economies, infrastructures, populations, public health and stability. As a consequence of natural disasters, governments may fail and populations may be decimated.

"Thus," Palmore writes, "planning for international security needs must take into account the effects of natural disasters.

"Since avian influenza is of utmost concern in Asia and in many other parts of the world, it is imperative that states' governments and nongovernmental organizations pa
'"/>

Contact: Melissa Mitchell, News Editor
melissa@uiuc.edu
217-333-5491
University of Illinois at Urbana-Champaign
24-Jan-2006


Page: 1 2 3

Related biology news :

1. Cat hair at home poses an allergy risk, particularly for young children
2. Replacement warhead program poses challenges for weapons complex
3. Carnegie Mellon researcher proposes development of artificial cells to fight disease
4. Malaria poses additional risks for first-time mothers
5. One-two particle punch poses greater risk for astronauts
6. Epilepsy drug poses high risk for fetal death and birth defects
7. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
8. SNM opposes new payment caps on imaging services detailed in Federal Deficit Reduction Act
9. Study proposes new method to investigate genetic hybridization
10. Respiratory syncytial virus poses a significant threat to elderly
11. Report proposes structure for national network of cord blood stem cell banks

Post Your Comments:
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
(Date:7/25/2014)... A new study by researchers from the University ... tiny nanosystems function, unlocking the potential to create ... study, which has been published in the prestigious ... a novel laser technique to examine in rich ... a small cluster containing an acetylene molecule and ...
(Date:7/25/2014)... 25, 2014 Lawrence Livermore scientists Charles ... Reuters list of " The World's Most Influential Scientific ... the 3,000 researchers who were identified by analyzing citation ... who published the highest-impact work (2002-2012 and 2012-2013). The ... combustion modeling . , "This recognition is a ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
Cached News: